HEADER HORMONE/GROWTH FACTOR 31-OCT-02 1N4H TITLE CHARACTERIZATION OF LIGANDS FOR THE ORPHAN NUCLEAR RECEPTOR RORBETA COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN; COMPND 5 SYNONYM: NUCLEAR RECEPTOR RZR-BETA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: STEROID RECEPTOR COACTIVATOR-1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: NR-2 BOX; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: RZR-BETA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 DE3; SOURCE 9 EXPRESSION_SYSTEM_TISSUE: BRAIN; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 12 MOL_ID: 2; SOURCE 13 SYNTHETIC: YES; SOURCE 14 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 15 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN). KEYWDS ALPHA-HELICAL SANDWICH, PROTEIN-PEPTIDE-LIGAND COMPLEX, HORMONE- KEYWDS 2 GROWTH FACTOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.STEHLIN-GAON,D.WILLMANN,S.SANGLIER,A.VAN DORSSELAER,J.-P.RENAUD, AUTHOR 2 D.MORAS,R.SCHUELE REVDAT 3 14-FEB-24 1N4H 1 REMARK REVDAT 2 24-FEB-09 1N4H 1 VERSN REVDAT 1 23-SEP-03 1N4H 0 JRNL AUTH C.STEHLIN-GAON,D.WILLMANN,D.ZEYER,S.SANGLIER, JRNL AUTH 2 A.VAN DORSSELAER,J.-P.RENAUD,D.MORAS,R.SCHUELE JRNL TITL ALL-TRANS RETINOIC ACID IS A LIGAND FOR THE ORPHAN NUCLEAR JRNL TITL 2 RECEPTOR RORBETA JRNL REF NAT.STRUCT.BIOL. V. 10 820 2003 JRNL REFN ISSN 1072-8368 JRNL PMID 12958591 JRNL DOI 10.1038/NSB979 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.STEHLIN,J.M.WURTZ,A.STEINMETZ,E.GREINER,R.SCHULE,D.MORAS, REMARK 1 AUTH 2 J.P.RENAUD REMARK 1 TITL X-RAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORBETA REMARK 1 TITL 2 LIGAND-BINDING DOMAIN IN THE ACTIVE CONFORMATION REMARK 1 REF EMBO J. V. 20 5822 2001 REMARK 1 REFN ISSN 0261-4189 REMARK 1 DOI 10.1093/EMBOJ/20.21.5822 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.P.RENAUD,N.ROCHEL,M.RUFF,V.VIVAT,P.CHAMBON,H.GRONEMEYER, REMARK 1 AUTH 2 D.MORAS REMARK 1 TITL CRYSTAL STRUCTURE OF THE RAR-GAMMA LIGAND-BINDING DOMAIN REMARK 1 TITL 2 BOUND TO ALL-TRANS RETINOIC ACID REMARK 1 REF NATURE V. 378 681 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/378681A0 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 3.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 19024 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.217 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 16820 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2066 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 22 REMARK 3 SOLVENT ATOMS : 113 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.66200 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 4.87000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.20800 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.08 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.630 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : REAM.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N4H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-NOV-02. REMARK 100 THE DEPOSITION ID IS D_1000017507. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976205 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19390 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1K4W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.56 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, PH 8.0, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.09950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.01950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.06250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.01950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.09950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.06250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAIN(S). THE BIOLOGICAL UNIT IS REMARK 300 UNKNOWN. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1940 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -6 REMARK 465 GLN A -5 REMARK 465 LEU A -4 REMARK 465 ALA A -3 REMARK 465 PRO A -2 REMARK 465 GLY A -1 REMARK 465 ILE A 0 REMARK 465 PRO A 245 REMARK 465 ASP A 246 REMARK 465 CYS A 247 REMARK 465 ALA A 248 REMARK 465 ALA A 249 REMARK 465 VAL A 250 REMARK 465 CYS A 251 REMARK 465 LYS A 252 REMARK 465 ARG B 690 REMARK 465 GLY B 701 REMARK 465 SER B 702 REMARK 465 PRO B 703 REMARK 465 SER B 704 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 167 -3.29 80.06 REMARK 500 ASN A 192 -125.80 -102.79 REMARK 500 HIS A 193 87.72 -15.14 REMARK 500 ASP A 195 110.41 65.34 REMARK 500 ASP A 196 -117.97 -113.73 REMARK 500 GLU A 197 -5.05 99.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE REA A 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1K4W RELATED DB: PDB REMARK 900 XRAY STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORBETA LIGAND- REMARK 900 BINDING DOMAIN IN THE ACTIVE CONFORMATION REMARK 900 RELATED ID: 2LBD RELATED DB: PDB REMARK 900 LIGAND-BINDING DOMAIN OF THE HUMAN HUMAN NUCLEAR RECEPTOR RXR-ALPHA DBREF 1N4H A -6 252 UNP P45446 RORB_RAT 201 459 DBREF 1N4H B 690 704 GB 1906028 AAB50242 686 700 SEQRES 1 A 259 GLY GLN LEU ALA PRO GLY ILE THR MET SER GLU ILE ASP SEQRES 2 A 259 ARG ILE ALA GLN ASN ILE ILE LYS SER HIS LEU GLU THR SEQRES 3 A 259 CYS GLN TYR THR MET GLU GLU LEU HIS GLN LEU ALA TRP SEQRES 4 A 259 GLN THR HIS THR TYR GLU GLU ILE LYS ALA TYR GLN SER SEQRES 5 A 259 LYS SER ARG GLU ALA LEU TRP GLN GLN CYS ALA ILE GLN SEQRES 6 A 259 ILE THR HIS ALA ILE GLN TYR VAL VAL GLU PHE ALA LYS SEQRES 7 A 259 ARG ILE THR GLY PHE MET GLU LEU CYS GLN ASN ASP GLN SEQRES 8 A 259 ILE LEU LEU LEU LYS SER GLY CYS LEU GLU VAL VAL LEU SEQRES 9 A 259 VAL ARG MET CYS ARG ALA PHE ASN PRO LEU ASN ASN THR SEQRES 10 A 259 VAL LEU PHE GLU GLY LYS TYR GLY GLY MET GLN MET PHE SEQRES 11 A 259 LYS ALA LEU GLY SER ASP ASP LEU VAL ASN GLU ALA PHE SEQRES 12 A 259 ASP PHE ALA LYS ASN LEU CYS SER LEU GLN LEU THR GLU SEQRES 13 A 259 GLU GLU ILE ALA LEU PHE SER SER ALA VAL LEU ILE SER SEQRES 14 A 259 PRO ASP ARG ALA TRP LEU LEU GLU PRO ARG LYS VAL GLN SEQRES 15 A 259 LYS LEU GLN GLU LYS ILE TYR PHE ALA LEU GLN HIS VAL SEQRES 16 A 259 ILE GLN LYS ASN HIS LEU ASP ASP GLU THR LEU ALA LYS SEQRES 17 A 259 LEU ILE ALA LYS ILE PRO THR ILE THR ALA VAL CYS ASN SEQRES 18 A 259 LEU HIS GLY GLU LYS LEU GLN VAL PHE LYS GLN SER HIS SEQRES 19 A 259 PRO ASP ILE VAL ASN THR LEU PHE PRO PRO LEU TYR LYS SEQRES 20 A 259 GLU LEU PHE ASN PRO ASP CYS ALA ALA VAL CYS LYS SEQRES 1 B 15 ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU GLY SER SEQRES 2 B 15 PRO SER HET REA A 500 22 HETNAM REA RETINOIC ACID FORMUL 3 REA C20 H28 O2 FORMUL 4 HOH *113(H2 O) HELIX 1 1 THR A 1 CYS A 20 1 20 HELIX 2 2 THR A 23 ALA A 31 1 9 HELIX 3 3 THR A 36 LYS A 46 1 11 HELIX 4 4 SER A 47 ARG A 72 1 26 HELIX 5 5 ILE A 73 GLU A 78 1 6 HELIX 6 6 CYS A 80 CYS A 101 1 22 HELIX 7 7 GLY A 119 GLY A 127 5 9 HELIX 8 8 SER A 128 SER A 144 1 17 HELIX 9 9 THR A 148 ILE A 161 1 14 HELIX 10 10 GLU A 170 ASN A 192 1 23 HELIX 11 11 GLU A 197 ALA A 204 1 8 HELIX 12 12 LYS A 205 HIS A 227 1 23 HELIX 13 13 HIS A 227 LEU A 234 1 8 HELIX 14 14 PRO A 236 ASN A 244 1 9 HELIX 15 15 HIS B 691 GLU B 700 1 10 SHEET 1 A 3 PHE A 104 ASN A 105 0 SHEET 2 A 3 THR A 110 PHE A 113 -1 O THR A 110 N ASN A 105 SHEET 3 A 3 LYS A 116 GLY A 118 -1 O LYS A 116 N PHE A 113 SITE 1 AC1 8 GLN A 21 TYR A 22 CYS A 55 ARG A 99 SITE 2 AC1 8 VAL A 111 LEU A 112 HOH A 801 HOH A 823 CRYST1 52.199 58.125 106.039 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019157 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009430 0.00000 CONECT 2069 2070 2074 2084 2085 CONECT 2070 2069 2071 CONECT 2071 2070 2072 CONECT 2072 2071 2073 CONECT 2073 2072 2074 2086 CONECT 2074 2069 2073 2075 CONECT 2075 2074 2076 CONECT 2076 2075 2077 CONECT 2077 2076 2078 2087 CONECT 2078 2077 2079 CONECT 2079 2078 2080 CONECT 2080 2079 2081 CONECT 2081 2080 2082 2088 CONECT 2082 2081 2083 CONECT 2083 2082 2089 2090 CONECT 2084 2069 CONECT 2085 2069 CONECT 2086 2073 CONECT 2087 2077 CONECT 2088 2081 CONECT 2089 2083 CONECT 2090 2083 MASTER 297 0 1 15 3 0 2 6 2201 2 22 22 END